Skip to content

China

Mushrooms fuel wealth in remote county

  • by

Yang Tao, deputy general manager of Qingyuan County Junbo Biotechnology Co Ltd, checks shiitake mushrooms in an intelligent drying unit in Qingyuan county, East China’s Zhejiang province, on Dec 9, 2025. [Photo/Xinhua] HANGZHOU — Nestled in the remote mountains of Zhejiang province, Qingyuan county has transformed its lush forests into a source of sustainable wealth…

Green shoots sprout in fashion landscape

  • by

A blue-and-white porcelain-themed sculpture featuring Oriental aesthetic art is on display at Taikoo Li Sanlitun, Chaoyang district, Beijing, on Dec 14. CHINA DAILY Visitors to Taikoo Li Sanlitun, one of Beijing’s leading fashion and lifestyle destinations, can hardly miss the shift underway this winter. Three freshly opened stores — Dior, Tiffany & Co and Louis…

South Korea’s Musinsa expanding in China

  • by

The back-to-back opening of two stores by South Korea’s fast-rising fashion group Musinsa in Shanghai this month is more than an offline expansion in the Chinese market. It reflects a broader shift in how overseas fashion players are entering the market, betting on local partnerships, value-driven positioning and designer fashion trends. Often dubbed the “South…

China approves new drug for rare joint tumor

  • by

Germany-headquartered science and technology giant Merck announced that pimicotinib, a colony-stimulating factor-1 receptor (CSF-1R) inhibitor, has been approved in China on Monday, bringing a new treatment option to adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity. TGCT is a rare but…

Artificial intelligence fuels healthcare innovation in China

  • by

The wider adoption of artificial intelligence across healthcare is underpinning the Healthy China Initiative while fostering new quality productive forces in the healthcare sector, experts said. “Artificial intelligence has a far-reaching impact on technological progress and human life, with medicine likely to become its most widely used and valuable application,” said Fan Xianqun, dean of…

DJI ‘disappointed’ by US move to block authorizations for foreign-made drones

  • by

In this photo illustration, a DJI Mavic 2 Pro made by the Chinese drone maker hovers in place on Dec 15, 2021 in Miami, Florida. [Photo/Agencies] SHENZHEN – Chinese drone giant DJI expressed disappointment on Tuesday regarding the US Federal Communications Commission’s (FCC) decision to add foreign-made drones to the “Covered List”. Updated on Monday,…

Major CO2 power generator starts operations

  • by

Employees of China National Nuclear Corp work at a supportive facility for Chaotan One, the world’s first commercial supercritical carbon dioxide power generator, in Liupanshui, Guizhou province, on Saturday. XIAO YAN/XINHUA The world’s first commercial supercritical carbon dioxide power generator started operations in Southwest China’s Guizhou province recently, a significant milestone in the global transition…

SOEs to focus on core sectors, real economy

  • by

A robot is displayed at the exhibition area of the 2025 Global Industrial Internet Conference in Shenyang, Northeast China’s Liaoning province, Sept 6, 2025. [Photo/Xinhua] Central State-owned enterprises will focus on core sectors and the real economy in the upcoming 15th Five-Year Plan (2026-30) period to move up the value chain and lead the push…

Chinese shipbuilder announces doubling of LNG vessel construction capacity

  • by

With the delivery of Ocean Oasis, a 174,000-cubic-meter LNG vessel, on Friday, Hudong-Zhonghua Shipbuilding (Group) Co, a unit of the world’s largest shipbuilder, China State Shipbuilding Corp, announced that it has doubled its LNG ship production capacity during the 14th Five-Year Plan (2021-25) period. [Photo provided to chinadaily.com.cn] With the delivery of Ocean Oasis, a…

AstraZeneca in cancer drug deal with Chinese biotech firm

  • by

AstraZeneca has entered a global licensing agreement with Jacobio Pharmaceuticals, a Hong Kong-listed Chinese biotech company, to develop and commercialize a clinical-stage KRAS cancer drug candidate, the two companies announced on Monday. Under the agreement, the United Kingdom-based pharmaceutical company will obtain exclusive rights to develop and commercialize the pan-KRAS inhibitor JAB-23E73 outside the Chinese…